REGN
Price
$807.67
Change
+$2.65 (+0.33%)
Updated
Oct 26 closing price
Capitalization
83.15B
3 days until earnings call
Intraday BUY SELL Signals
THQ
Price
$18.29
Change
-$0.09 (-0.49%)
Updated
Oct 26 closing price
Net Assets
819.21M
Intraday BUY SELL Signals
Interact to see
Advertisement

REGN vs THQ

REGN vs THQ Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
REGN vs. THQ commentary
Oct 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REGN is a Buy and THQ is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for REGN with price predictions
Oct 26, 2026

REGN in upward trend: price rose above 50-day moving average on October 20, 2026

REGN moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend. In 29 of 38 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 76%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where REGN's RSI Indicator exited the oversold zone, 19 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.

The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on REGN as a result. In 57 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.

The Moving Average Convergence Divergence (MACD) for REGN just turned positive on October 14, 2026. Looking at past instances where REGN's MACD turned positive, the stock continued to rise in 31 of 49 cases over the following month. The odds of a continued upward trend are 63%.

The 10-day moving average for REGN crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 73%.

Following a +5.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where REGN advanced for three days, in 207 of 318 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where REGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.

REGN broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for REGN entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 21 (best 1 - 100 worst), indicating outstanding price growth. REGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 79 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. REGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.622) is normal, around the industry mean (3.037). P/E Ratio (19.290) is within average values for comparable stocks, (-1.223). Projected Growth (PEG Ratio) (1.238) is also within normal values, averaging (9.059). Dividend Yield (0.005) settles around the average of (135.883) among similar stocks. P/S Ratio (5.339) is also within normal values, averaging (439.237).

A.I.Advisor
a Summary for THQ with price predictions
Oct 26, 2026

Momentum Indicator for THQ turns positive, indicating new upward trend

THQ saw its Momentum Indicator move above the 0 level on October 15, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned positive. In 70 of the 80 cases, the stock moved higher in the following days. The odds of a move higher are at 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where THQ's RSI Indicator exited the oversold zone, 22 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.

The Moving Average Convergence Divergence (MACD) for THQ just turned positive on October 15, 2026. Looking at past instances where THQ's MACD turned positive, the stock continued to rise in 46 of 56 cases over the following month. The odds of a continued upward trend are 82%.

Following a +0.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where THQ advanced for three days, in 265 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

THQ moved below its 50-day moving average on October 23, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for THQ crossed bearishly below the 50-day moving average on September 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where THQ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

THQ broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for THQ entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

FUNDAMENTALS RATINGS
REGN: Fundamental Ratings
REGN
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
79
SMR RATING
1..100
59
PRICE GROWTH RATING
1..100
21
P/E GROWTH RATING
1..100
15
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
REGNTHQ
RSI
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
53%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
65%
Bearish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 12 days ago
65%
Bullish Trend 5 days ago
84%
Declines
ODDS (%)
Bearish Trend 8 days ago
56%
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
53%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
78%
COMPARISON
Comparison
Oct 27, 2026
Stock price -- (REGN: $807.67)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

REGN’s FA Score shows that 2 FA rating(s) are green while .

  • REGN’s FA Score: 2 green, 3 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

REGN’s TA Score shows that 6 TA indicator(s) are bullish.

  • REGN’s TA Score: 6 bullish, 4 bearish.

Price Growth

REGN (@Biotechnology) experienced а +3.28% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.45%. For the same industry, the average monthly price growth was -15.42%, and the average quarterly price growth was -14.11%.

Reported Earning Dates

REGN is expected to report earnings on Oct 30, 2026.

Industries' Descriptions

@Biotechnology (-0.45% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
REGN
Daily Signal:
Gain/Loss:
THQ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

THQ and

Correlation & Price change

A.I.dvisor tells us that THQ and DHR have been poorly correlated (+13% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that THQ and DHR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THQ
1D Price
Change %
THQ100%
-0.49%
DHR - THQ
13%
Poorly correlated
+1.07%
ABBV - THQ
13%
Poorly correlated
+0.39%
UNH - THQ
10%
Poorly correlated
-1.77%
REGN - THQ
10%
Poorly correlated
+0.33%
MRK - THQ
9%
Poorly correlated
-3.21%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASC20.700.67
+3.34%
ARDMORE SHIPPING Corp
DXCM78.570.63
+0.81%
DexCom
MRP23.910.05
+0.21%
Millrose Properties Inc
BENF0.79-0.01
-0.99%
Beneficient
MRT1.95-0.05
-2.50%
Marti Technologies